Cite
Renner K, Seilbeck A, Kauer N, et al. Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells. Front Pharmacol. 2018;9:1258doi: 10.3389/fphar.2018.01258.
Renner, K., Seilbeck, A., Kauer, N., Ugele, I., Siska, P. J., Brummer, C., Bruss, C., Decking, S. M., Fante, M., Schmidt, A., Hammon, K., Singer, K., Klobuch, S., Thomas, S., Gottfried, E., Peter, K., & Kreutz, M. (2018). Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells. Frontiers in pharmacology, 91258. https://doi.org/10.3389/fphar.2018.01258
Renner, Kathrin, et al. "Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells." Frontiers in pharmacology vol. 9 (2018): 1258. doi: https://doi.org/10.3389/fphar.2018.01258
Renner K, Seilbeck A, Kauer N, Ugele I, Siska PJ, Brummer C, Bruss C, Decking SM, Fante M, Schmidt A, Hammon K, Singer K, Klobuch S, Thomas S, Gottfried E, Peter K, Kreutz M. Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells. Front Pharmacol. 2018 Nov 02;9:1258. doi: 10.3389/fphar.2018.01258. eCollection 2018. PMID: 30450049; PMCID: PMC6224440.
Copy
Download .nbib